Source: Investigational New Drugs. Unidade: FMRP
Subjects: GENES, FÁRMACOS (COMBINAÇÃO), RADIOTERAPIA
ABNT
CASTRO-GAMERO, Angel Mauricio et al. Tetra-O-methyl nordihydroguaiaretic acid, an inhibitor of Sp1-mediated survivin transcription, induces apoptosis and acts synergistically with chemo-radiotherapy in glioblastoma cells. Investigational New Drugs, v. 31, n. 4, p. 858-870, 2013Tradução . . Disponível em: https://doi.org/10.1007/s10637-012-9917-4. Acesso em: 02 nov. 2024.APA
Castro-Gamero, A. M., Borges, K. S., Moreno, D. A., Suazo, V. K., Fujinami, M. M., Queiroz, R. G. de P., et al. (2013). Tetra-O-methyl nordihydroguaiaretic acid, an inhibitor of Sp1-mediated survivin transcription, induces apoptosis and acts synergistically with chemo-radiotherapy in glioblastoma cells. Investigational New Drugs, 31( 4), 858-870. doi:10.1007/s10637-012-9917-4NLM
Castro-Gamero AM, Borges KS, Moreno DA, Suazo VK, Fujinami MM, Queiroz RG de P, Oliveira HF de, Carlotti Júnior CG, Scrideli CA, Tone LG. Tetra-O-methyl nordihydroguaiaretic acid, an inhibitor of Sp1-mediated survivin transcription, induces apoptosis and acts synergistically with chemo-radiotherapy in glioblastoma cells [Internet]. Investigational New Drugs. 2013 ; 31( 4): 858-870.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1007/s10637-012-9917-4Vancouver
Castro-Gamero AM, Borges KS, Moreno DA, Suazo VK, Fujinami MM, Queiroz RG de P, Oliveira HF de, Carlotti Júnior CG, Scrideli CA, Tone LG. Tetra-O-methyl nordihydroguaiaretic acid, an inhibitor of Sp1-mediated survivin transcription, induces apoptosis and acts synergistically with chemo-radiotherapy in glioblastoma cells [Internet]. Investigational New Drugs. 2013 ; 31( 4): 858-870.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1007/s10637-012-9917-4